Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells

Jemal, 2009, Cancer statistics, CA Can. J. Clin., 59, 225, 10.3322/caac.20006 Costa, 2007, Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies, Oncologist, 12, 1404, 10.1634/theoncologist.12-12-1404 Flanigan, 2003, Metastatic renal cell carcinoma, Curr. Treat. Options Oncol., 4, 385, 10.1007/s11864-003-0039-2 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100 Singh, 2003, Identification of a cancer stem cell in human brain tumors, Can. Res., 63, 5821 Addla, 2008, Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells, Am. J. Physiol. Renal Physiol., 295, F680, 10.1152/ajprenal.90286.2008 Bussolati, 2008, Identification of a tumor-initiating stem cell population in human renal carcinomas, FASEB J., 22, 3696, 10.1096/fj.08-102590 Reynolds, 1992, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255, 1707, 10.1126/science.1553558 Ponti, 2005, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties, Can. Res., 65, 5506, 10.1158/0008-5472.CAN-05-0626 Cariati, 2008, Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line, Int. J. Can., 122, 298, 10.1002/ijc.23103 Yu, 2008, Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87, Can. Lett., 265, 124, 10.1016/j.canlet.2008.02.010 Fang, 2005, A tumorigenic subpopulation with stem cell properties in melanomas, Can. Res., 65, 9328, 10.1158/0008-5472.CAN-05-1343 Eramo, 2008, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ., 15, 504, 10.1038/sj.cdd.4402283 Gibbs, 2005, Stem-like cells in bone sarcomas: implications for tumorigenesis, Neoplasia, 7, 967, 10.1593/neo.05394 Groszer, 2001, Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo, Science, 294, 2186, 10.1126/science.1065518 Zhong, 2007, Most MCF7 and SK-OV3 cells were deprived of their stem nature by Hoechst 33342, Biochem. Biophys. Res. Commun., 364, 338, 10.1016/j.bbrc.2007.10.016 Ghods, 2007, Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells, Stem Cells, 25, 1645, 10.1634/stemcells.2006-0624 Ho, 2007, Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells, Can. Res., 67, 4827, 10.1158/0008-5472.CAN-06-3557 Wu, 2007, Side population cells isolated from mesenchymal neoplasms have tumor initiating potential, Can. Res., 67, 8216, 10.1158/0008-5472.CAN-07-0999 Sagrinati, 2006, Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys, J. Am. Soc. Nephrol., 17, 2443, 10.1681/ASN.2006010089 Patrawala, 2006, Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells, Oncogene, 25, 1696, 10.1038/sj.onc.1209327 Seliger, 2000, HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes, Int. J. Can., 87, 349, 10.1002/1097-0215(20000801)87:3<349::AID-IJC7>3.0.CO;2-O Fan, 2005, Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues, Clin. Can. Res., 11, 4331, 10.1158/1078-0432.CCR-05-0099 Schatton, 2010, Modulation of T-cell activation by malignant melanoma initiating cells, Can. Res., 70, 697, 10.1158/0008-5472.CAN-09-1592 Kawasaki, 2008, Cancer stem cells, CD200 and immunoevasion, Trends Immunol., 29, 464, 10.1016/j.it.2008.07.005 Kawasaki, 2007, Co-expression of the toleragenic, glycoprotein, CD200, with markers for cancer stem cells, Biochem. Biophys. Res. Commun., 364, 778, 10.1016/j.bbrc.2007.10.067 Zou, 2008, Inhibitory B7-family molecules in the tumour microenvironment, Nat. Rev. Immunol., 8, 467, 10.1038/nri2326 Rabinovich, 2007, Immunosuppressive strategies that are mediated by tumor cells, Annu. Rev. Immunol., 25, 267, 10.1146/annurev.immunol.25.022106.141609 Ebert, 2008, The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells, Can. Res., 68, 3001, 10.1158/0008-5472.CAN-07-5664 Hinz, 2007, Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer, Can. Res., 67, 8344, 10.1158/0008-5472.CAN-06-3304 Kohga, 2010, Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma, J. Hepatol., 52, 872, 10.1016/j.jhep.2009.12.030 Di Tomaso, 2010, Immunobiological characterization of cancer stem cells isolated from glioblastoma patients, Clin. Can. Res., 16, 800, 10.1158/1078-0432.CCR-09-2730 Fishelson, 2003, Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors, Mol. Immunol., 40, 109, 10.1016/S0161-5890(03)00112-3 Clarke, 2006, Cancer stem cells – perspectives on current status and future directions: AACR workshop on cancer stem cells, Can. Res., 66, 9339, 10.1158/0008-5472.CAN-06-3126 Dalerba, 2007, Cancer stem cells: models and concepts, Annu. Rev. Med., 58, 267, 10.1146/annurev.med.58.062105.204854 Dean, 2005, Tumour stem cells and drug resistance, Nat. Rev. Can., 5, 275, 10.1038/nrc1590 Chambers, 2004, Self-renewal of teratocarcinoma and embryonic stem cells, Oncogene, 23, 7150, 10.1038/sj.onc.1207930 Hurt, 2008, CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis, Br. J. Can., 98, 756, 10.1038/sj.bjc.6604242 Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005 Shiina, 2003, The human T-cell factor-4 gene splicing isoforms Wnt signal pathway, and apoptosis in renal cell carcinoma, Clin. Can. Res., 9, 2121 Guo, 2008, Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation, Nature, 453, 529, 10.1038/nature06933 Malanchi, 2008, Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling, Nature, 452, 650, 10.1038/nature06835 Chambers, 2003, Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells, Cell, 113, 643, 10.1016/S0092-8674(03)00392-1 Gu, 2007, Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo, Can. Res., 67, 4807, 10.1158/0008-5472.CAN-06-4608 Wei, 2010, Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway, Mol. Can. Ther., 9, 67, 10.1158/1535-7163.MCT-09-0734 Khong, 2002, Natural selection of tumor variants in the generation of “tumor escape” phenotypes, Nat. Immunol., 3, 999, 10.1038/ni1102-999 Martin, 2010, Human FOXP3 and cancer, Oncogene, 10.1038/onc.2010.174 Cerwenka, 2001, Natural killer cells viruses and cancer, Nat. Rev. Immunol., 1, 41, 10.1038/35095564 Bottino, 2005, Cellular ligands of activating NK receptors, Trends Immunol., 26, 221, 10.1016/j.it.2005.02.007 El-Sherbiny, 2007, The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells, Can. Res., 67, 8444, 10.1158/0008-5472.CAN-06-4230 Parham, 2005, MHC class I molecules and KIRs in human history, health and survival, Nat. Rev. Immunol., 5, 201, 10.1038/nri1570 Castriconi, 2009, NK cells recognize and kill human glioblastoma cells with stem cell-like properties, J. Immunol., 182, 3530, 10.4049/jimmunol.0802845 Raulet, 2003, Roles of the NKG2D immunoreceptor and its ligands, Nat. Rev. Immunol., 3, 781, 10.1038/nri1199 Maccalli, 2007, NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients, Clin. Can. Res., 13, 7459, 10.1158/1078-0432.CCR-07-1166